Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio-Techne (TECH) Return on Invested Capital (2016 - 2025)

Bio-Techne has reported Return on Invested Capital over the past 16 years, most recently at 0.01% for Q4 2025.

  • Quarterly results put Return on Invested Capital at 0.01% for Q4 2025, down 9.0% from a year ago — trailing twelve months through Dec 2025 was 0.01% (down 9.0% YoY), and the annual figure for FY2025 was 0.06%, down 15.0%.
  • Return on Invested Capital for Q4 2025 was 0.01% at Bio-Techne, up from 0.03% in the prior quarter.
  • Over the last five years, Return on Invested Capital for TECH hit a ceiling of 0.17% in Q1 2021 and a floor of 0.06% in Q2 2025.
  • Median Return on Invested Capital over the past 5 years was 0.08% (2021), compared with a mean of 0.07%.
  • Biggest five-year swings in Return on Invested Capital: grew 13bps in 2021 and later decreased -15bps in 2025.
  • Bio-Techne's Return on Invested Capital stood at 0.1% in 2021, then tumbled by -83bps to 0.02% in 2022, then skyrocketed by 499bps to 0.1% in 2023, then dropped by -24bps to 0.08% in 2024, then plummeted by -115bps to 0.01% in 2025.
  • The last three reported values for Return on Invested Capital were 0.01% (Q4 2025), 0.03% (Q3 2025), and 0.06% (Q2 2025) per Business Quant data.